Price T Rowe Associates Inc. MD increased its stake in Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) by 16.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 45,156 shares of the company’s stock after acquiring an additional 6,502 shares during the same period. Price T Rowe Associates Inc. MD owned about 0.09% of Nu Skin Enterprises worth $625,000, according to its most recent SEC filing.
Other institutional investors and hedge funds have also been buying and selling shares of the company. GAMMA Investing LLC acquired a new stake in Nu Skin Enterprises during the fourth quarter valued at around $33,000. CWM LLC increased its holdings in shares of Nu Skin Enterprises by 38.4% in the 1st quarter. CWM LLC now owns 3,286 shares of the company’s stock valued at $45,000 after buying an additional 911 shares in the last quarter. Covestor Ltd increased its stake in Nu Skin Enterprises by 90.1% in the 1st quarter. Covestor Ltd now owns 4,353 shares of the company’s stock valued at $60,000 after buying an additional 2,063 shares in the last quarter. Lazard Asset Management LLC increased its holdings in Nu Skin Enterprises by 92.7% in the 1st quarter. Lazard Asset Management LLC now owns 4,587 shares of the company’s stock valued at $63,000 after purchasing an additional 2,206 shares in the last quarter. Finally, Signaturefd LLC grew its position in Nu Skin Enterprises by 25.1% in the fourth quarter. Signaturefd LLC now owns 5,000 shares of the company’s stock valued at $97,000 after purchasing an additional 1,004 shares in the last quarter. 82.84% of the shares are owned by hedge funds and other institutional investors.
Nu Skin Enterprises share price rises 4.4%
Nu Skin Enterprises shares opened at $9.45 on Wednesday. The company has a debt-to-equity ratio of 0.56, a current debt ratio of 1.24 and a current liability ratio of 2.09. Nu Skin Enterprises, Inc. has a 52-week low of $8.80 and a 52-week high of $25.36. The company’s 50-day moving average price is $11.19 and its 200-day moving average price is $12.79. The stock has a market cap of $469.35 million, a price-to-earnings ratio of -157.50 and a beta of 1.13.
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last released its quarterly earnings results on Thursday, August 8. The company reported earnings per share (EPS) of $0.21 for the quarter, beating analysts’ consensus estimates of $0.17 by $0.04. The company posted revenue of $439.10 million for the quarter, compared to analyst expectations of $431.87 million. Nu Skin Enterprises had a negative net margin of 0.17% and a positive return on equity of 9.28%. The company’s revenue for the quarter decreased 12.2% compared to the same quarter last year. In the year-ago quarter, the company posted earnings per share of $0.54. Equities analysts forecast that Nu Skin Enterprises, Inc. will post earnings per share of $1.1 for the current year.
Nu Skin Enterprises Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 11. Shareholders of record on Friday, August 30th will receive a dividend of $0.06, representing an annualized dividend of $0.24 and a yield of 2.54%. The ex-dividend date is Friday, August 30th. Nu Skin Enterprises’ Dividend Payout Ratio (DPR) is currently -400.00%.
Insider transactions at Nu Skin Enterprises
In related news, Director Andrew D. Lipman sold 2,000 shares of the company’s stock on Tuesday, May 28. The shares were sold at an average price of $13.33, for a total value of $26,660.00. Following the completion of the sale, the director now owns 23,225 shares of the company’s stock, valued at $309,589.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.70% of the company’s stock.
Wall Street analysts comment
Several equities analysts have recently commented on the stock. DA Davidson lowered their price target on shares of Nu Skin Enterprises from $12.50 to $11.00 and gave the company a “neutral” rating in a report on Monday. Citigroup lowered their price target on shares of Nu Skin Enterprises from $14.00 to $11.50 and gave the company a “neutral” rating in a research note on Friday, August 9. Four analysts have rated the stock with a “hold” rating. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $16.50.
Get our latest report on NUS
About Nu Skin Enterprises
(Free report)
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. The company offers skin care devices, cosmetics and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, as well as Nutricentials skin care products.
Selected articles
Want to see which other hedge funds hold NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report).
Get daily news and reviews for Nu Skin Enterprises – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Nu Skin Enterprises and related companies with MarketBeat.com’s FREE daily email newsletter.
